MMRF CureCloud Research Initiative
Megadott ok: The MMRF has learned of the limitations of using a blood sample to collect genomic data, compared to a bone marrow aspirate. We decided that our resources are best served in other areas at this time.
Key facts
- Where
- Dallas, Hackensack, Norwalk és St Louis, Egyesült ÁllamokSee the 4 sites
Where in Egyesült Államok
- University of Texas Southwestern Medical CenterDallas, Egyesült ÁllamokNo longer taking part
- Hackensack University Medical CenterHackensack, Egyesült ÁllamokNo longer taking part
- Multiple Myeloma Research FoundationNorwalk, Egyesült ÁllamokNo longer taking part
- Washington University Medical CampusSt Louis, Egyesült ÁllamokNo longer taking part
Trial details
- Who runs it
- Multiple Myeloma Research Foundation
- Trial code
- NCT03657251
- Record updated
- 2024. január 5.
- Original description
The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.Read full original descriptionShow less
The MMRF CureCloud Multiple Myeloma Research Initiative
The MMRF CureCloud Research Initiative, a Direct-to-Patient Research effort aimed at enrolling 5,000 individuals from whom comprehensive molecular and immune analyses will be generated from blood specimens and the resulting data aggregated with the correlating clinical information. Blood will be collected from all participants after electronic online consenting via a mailed blood kit designed for a mobile phlebotomy appointment. Through the consenting process, participants will also be authorizing collection of their electronic medical records information.
Inclusion: Patients diagnosed with active Multiple Myeloma; Patients have signed an online consent form.
Exclusion: Patients who live outside the United States; Patients with a diagnosis other than Multiple Myeloma or a known or suspected precursor to Multiple Myeloma.